Kato, Masaki

Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients

Serretti, A., Kato, M., De Ronchi, D., & Kinoshita, T. (2007) · Molecular Psychiatry

Neurotransmitter Receptor Influence on BehaviorTreatment of Major Depression

Cited by 529

Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder

Kato, M., & Serretti, A. (2010) · Molecular Psychiatry

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 450

Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis

Kato, M., Hori, H., Inoue, T., Iga, J., Iwata, M., Inagaki, T., Shinohara, K., Imai, H., Murata, A., Mishima, K., et al. (2021) · Molecular Psychiatry

Treatment of Major DepressionMental Health Treatment and Access

Cited by 152

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response

Biernacka, J. M., Sangkuhl, K., Jenkins, G., Whaley, R. M., Barman, P., Batzler, A., Altman, R. B., Arolt, V, Brockmöller, J., Chen, C. H., et al. (2015) · Translational Psychiatry

Treatment of Major DepressionGenetic Associations and Epidemiology

Cited by 140

Relapse and its modifiers in major depressive disorder after antidepressant discontinuation: meta-analysis and meta-regression

Kishi, T., Sakuma, K., Hatano, M., Okuya, M., Matsuda, Y., Kato, M., & Iwata, N. (2023) · Molecular Psychiatry

Treatment of Major DepressionMental Health Treatment and Access

Cited by 26

Therapeutic response to paroxetine in major depressive disorder predicted by DNA Methylation

Takeuchi, N., Nonen, S., Kato, M., Wakeno, M., Takekita, Y., Kinoshita, T., & Kugawa, F. (2017) · Neuropsychobiology

Treatment of Major DepressionEpigenetics and DNA Methylation

Cited by 26

Multiple Pre-Treatment miRNAs Levels in Untreated Major Depressive Disorder Patients Predict Early Response to Antidepressants and Interact with Key Pathways

Kato, M., Ogata, H., Tahara, H., Shimamoto, A., Takekita, Y., Koshikawa, Y., Nishida, K., Nonen, S., Higasa, K., & Kinoshita, T. (2022) · International Journal of Molecular Sciences

Treatment of Major DepressionMicroRNA in disease regulation

Cited by 23

Assessing reliability and validity of the oxford depression questionnaire (ODQ) in a Japanese clinical population

Kato, M., Kikuchi, T., Watanabe, K., Sumiyoshi, T., Moriguchi, Y., Åström, D., & Christensen, M. (2023) · Neuropsychiatric Disease and Treatment

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 3